About Us
Company History
Our Mission
Management Team
Board of Directors
Technology
The Problem
The Solution: Our Microbial Platforms
C1
Dapibus™
Advantages and Opportunities
Pipeline
Human Health
Animal Health
Alternative Proteins
Partners
Investors
Overview
Press Releases
SEC Filings
Financials
Investor Fact Sheet
Analyst Coverage
Corporate Governance
Annual Meeting and Proxy
Stock Information
Earnings Calls
Email Alert Opt-in
Media
Articles
Events
Presentations
Press Releases
Scientific Publications
Video Gallery
Contact Us
testing
sdfsdf
Search
Search
Recent Posts
Dyadic to Participate at Upcoming Events in June
Dyadic Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
Dyadic to Participate at Two Industry Events in May
Dyadic Announces Collaboration to Commercialize Animal-Free Alternative Proteins Using Dapibus™
Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
Recent Comments
No comments to show.
